You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS G12C Mutant Advanced Solid Tumor; NSCLC; CRC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Trial in Irving, San Antonio,

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors
  • Assigned interventions
  • Irving, Texas
  • +2 more
Nov 7, 2023

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +10 more
  • Boston, Massachusetts
  • +5 more
Jan 11, 2023

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

NSCLC, CRC, Solid Tumor Trial in Beijing (JAB-21822)

Recruiting
  • NSCLC
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Aug 11, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Advanced Solid Tumor, NSCLC, CRC Trial in United States (JAB-21822 (KRAS G12C inhibitor), Cetuximab (EGFR inhibitor))

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • JAB-21822 (KRAS G12C inhibitor)
  • Cetuximab (EGFR inhibitor)
  • Phoenix, Arizona
  • +3 more
Sep 7, 2021

Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Adelaide, South Australia, Australia
    Cancer Research SA
Aug 15, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma Trial in Nashville, San Antonio, Fairfax (RMC-6291)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 16, 2022

KRAS G12C Trial in Guangzhou (GFH925)

Recruiting
  • KRAS G12C
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 1, 2022

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Sep 8, 2023

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

Efficacy Trial in Seoul (Oral sotorasib + IV Panitumumab)

Active, not recruiting
  • Efficacy
  • Oral sotorasib + IV Panitumumab
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Aug 14, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Solid Tumor, Advanced Solid Tumor, NSCLC Trial (MRTX1133)

Not yet recruiting
  • Solid Tumor
  • +4 more
  • (no location specified)
Feb 21, 2023

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023